Join us as we explore blood transfusion safety, focusing specifically on Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO). Tailored for general hematologists with a foundational understanding of transfusion medicine, this session delves into the pathophysiology, clinical presentation, diagnostic criteria, and management strategies for TRALI and TACO. Through advanced discussions, participants will deepen their knowledge of these...

Are you a hematologist or a generalist provider seeking clarity on how to best counsel patients with sickle cell disease (SCD) who are interested in gene therapy? Join us for a podcast session focused on important patient considerations for gene therapy, tailored for SCD providers and clinicians. This session aims to provide practical insights to facilitate clear communication between providers, patients with SCD, and their families about treatment options. Learning Objectives Understand the...

Speakers: Alexis Thompson, MD, and Sujit Sheth, MD Description: For general hematologists with a foundational understanding of thalassemia, this episode discusses the changing demographics due to immigration and refugee resettlement. It covers the diagnosis process from newborn screening to older individuals, emphasizing genetic testing due to numerous mutations and varied phenotypes. The importance of correctly diagnosing older individuals previously misdiagnosed with iron deficiency...

Dr. Azam Farooqui (@azamfarooqui ) and Dr. Monique Hartley-Brown (@DrMHB1) discuss therapeutic considerations regarding current and emerging agents for patients with multiple myeloma from underrepresented racial and ethnic groups. Coming Soon! Prepare to enhance your knowledge through the IMPACT II online learning module on ASH Academy On Demand! Participants will develop an increased ability to identify variations in factors influencing mortality and survival outcomes among individuals from...

Dr. Azam Farooqui (@azamfarooqui )and Dr. Sikander Ailawadhi answer the question: Why do we need earlier diagnosis and intervention in patients with multiple myeloma from underrepresented racial and ethnic groups? Coming Soon! Prepare to enhance your knowledge through the IMPACT II online learning module on ASH Academy On Demand! Participants will develop an increased ability to identify variations in factors influencing mortality and survival outcomes among individuals from racial and...

Dr. Azam Farooqui (@azamfarooqui) and Dr. Urvi Shah (@UrviShahMD) identify factors that impact outcomes for patients with multiple myeloma from underrepresented racial and ethnic groups. Coming Soon! Prepare to enhance your knowledge through the IMPACT II online learning module on ASH Academy On Demand! Participants will develop an increased ability to identify variations in factors influencing mortality and survival outcomes among individuals from racial and ethnic minority groups with...

Season 2: IMPACT II: Impacting Multiple Myeloma in All CommuniTies Unlock insights into the treatment of multiple myeloma within underrepresented racial and ethnic populations with this series of three enlightening podcast episodes. Join experts from both academic and community oncology settings as they dive into critical aspects of clinical risk, survival outcomes, and treatment considerations. Episode 1: Uncover the factors influencing outcomes for multiple myeloma patients from...

Dr. Michael Diaz (@mdiazoncmd) and Dr. Namrata Chandhok (@NamrataChandhok) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with myelodysplastic syndromes and clonal hematopoiesis. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between the American Society of Hematology and the Leukemia & Lymphoma Society. Access and complete...

Dr. Michael Diaz (@mdiazoncmd) and Dr. James Blachly (@jamesblachly) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with acute myeloid leukemia. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between the American Society of Hematology and the Leukemia & Lymphoma Society. Access and complete the GENOM modules (for which you can...

Dr. Michael Diaz (@mdiazoncmd) and Dr. Emily K. Curran (@ECurranMD) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with acute lymphoblastic leukemia. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between the American Society of Hematology and the Leukemia & Lymphoma Society. Access and complete the GENOM modules (for which...

Dr. Sanjay Juneja (@TheRealOncDoc) and Dr. Ajai Chari (@AjaiChari) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with myeloma. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between the American Society of Hematology and the Leukemia & Lymphoma Society. Access and complete the GENOM modules (for which you can claim CME and...

Dr. Sanjay Juneja (@TheRealOncDoc) and Dr. David Russler-Germain (@dgermain21) discuss the importance of genomic testing and how to understand and interpret test results when treating patients with lymphoma. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between the American Society of Hematology and the Leukemia & Lymphoma Society. Access and complete the GENOM modules (for which you can...

Dr. Sanjay Juneja (@TheRealOncDoc) and Dr. Jacqueline Barrientos discuss the importance of genomic testing and how to understand and interpret test results when treating patients with chronic lymphocytic leukemia (CLL). They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies. This project is a collaboration between the American Society of Hematology and the Leukemia & Lymphoma Society. Access and complete the GENOM modules (for which...

HemeTalks: Conversations in Hematology Education is a brand-new podcast from the American Society of Hematology (ASH)! Listen to educational content from ASH developed by subject-matter experts to meet your professional education needs. Whether you’re a clinician or researcher, ASH has innovative education for every career stage and subspecialty.    Season 1, Genomics Essentials in Hematologic Malignancies: Perspectives, will launch next week! Six, 15-minute episodes featuring faculty from...